MALACHITE INNOVATIONS, INC.

(MLCT)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
05/16INSIDER SELL : Seagen
MT
05/16Seagen's President, CEO Clay Siegall Resigns Amid Investigation
MT
05/13SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/13Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/11Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
05/11Moderna, Inc. Fires Jorge Gomez as CFO
CI
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11Moderna Ousts New Finance Chief Amid Probe at Dentsply
DJ
05/11Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO
MT
05/11Moderna CFO, Jorge Gomez, Resigns Effective Immediately
MT
05/11Moderna CFO exits a day after taking charge as former employer launches probe
RE
05/11Moderna's new CFO Jorge Gomez steps down
RE
05/10What you need to know about the coronavirus right now
RE
05/10Novavax shares slide 20% on COVID vaccine demand uncertainty
RE
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
05/09Novavax 2022 COVID vaccine deliveries off to slow start, shares drop
RE
05/09Novavax posts drop in COVID research funding, slow start to 2022 vaccine delivery
RE
05/09SECTOR UPDATE : Health Care Stocks Declining Ahead of Monday Close
MT
05/09SECTOR UPDATE : Health Care
MT
05/09Seagen's Shares Drop After CEO Clay Siegall Takes Leave of Absence; Roger Dansey Named ..
MT
05/09Top Midday Decliners
MT
05/09Equities Drop Midday as Economic Growth, Inflation Concerns Mount
MT
05/09Seagen CEO Clay Siegall Takes Leave of Absence; Roger Dansey Named Interim CEO
MT
05/09COVID vaccine makers shift focus to boosters
RE
05/09Seagen Inc. Announces CEO Changes
CI
05/09Seagen President, CEO and Chairman Clay Siegall Takes Leave of Absence
CI
05/06Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from var..
RE
05/06EuroAPI gains on market debut after spin-off from Sanofi
RE
05/05U.S. limits use of J&J's COVID vaccine on blood clot risks
RE
05/05TikoMed AB and IQVIA Announce Strategic Collaboration for the Development of TikoMed's ..
CI
05/04INSIDER SELL : Moderna
MT
05/04Moderna Beats First-Quarter Views on Vaccine Sales Surge, Sees Need For Booster Doses i..
MT
05/04TRANSCRIPT : IQVIA Holdings Inc. - Special Call
CI
05/04SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
05/04TRANSCRIPT : Moderna, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Moderna's Q1 Earnings, Revenue Rise -- Shares Gain Pre-Bell
MT
05/04Moderna sees higher COVID vaccine sales later this year
RE
05/04Moderna, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/04Moderna keeps full-year COVID vaccine sales view unchanged
RE
05/04Earnings Flash (MRNA) MODERNA Posts Q1 Revenue $6.07B, vs. Street Est of $4.426B
MT
05/03Declaration of Voting Results by Moderna, Inc
CI
05/02Moderna says its vaccine for ages under 6 will be ready for U.S. review in June
RE
05/02Poland has no 'rationale to invoke force majeure in Pfizer vaccine deal -EU official
RE
05/02Moderna's COVID-19 Vaccine For Children Under Six To Be Ready For US FDA Review In June
MT
04/29RBC Capital Adjusts Seagen's Price Target to $136 From $132, Maintains Sector Perform R..
MT
04/29Moderna Seeks European Nod for COVID-19 Vaccine for Kids Under Six
MT
04/29IQVIA Holdings Shares Rise Midday Following Piper Upgrade, Target Increase
MT
1  2  3  4  5  6  7  8  9  10Next